Successful treatment of sepsis caused by Staphylococcus lugdunensis in an adult with 22q11.2 deletion syndrome

Internal Medicine

Volumn 51, Issue 4, 2012, Pages 377-380

  Hirasaki, Shoji ^a,b   Murakami, Kazutoshi ^a   Mizushima, Takaaki ^a   Ohmori, Kazuyoshi ^a   Fujita, Seiko ^a   Hanayama, Yoshihisa ^a   Kanamori, Tatsuya ^a   Yokota, Ryo ^a   Ebara, Hirotaka ^a   Kusano, Nobuchika ^a   Kudo, Chieko ^c   Yamaguchi, Tomoko ^c   Akagi, Teiji ^c   Koide, Norio ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b Kousei Hospital   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Blood culture; Dental disease; Staphylococcal infection; Tetralogy of fallot

Indexed keywords

C REACTIVE PROTEIN; CLINDAMYCIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; CALCIUM BLOOD LEVEL; CASE REPORT; CHROMOSOME DELETION 22Q11; DENTAL CARIES; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ENAMEL HYPOPLASIA; FALLOT TETRALOGY; FATIGUE; FEMALE; FEVER; GENOTYPE; GINGIVITIS; HUMAN; HYPERTELORISM; HYPOPLASIA; LYMPHOCYTE COUNT; MALOCCLUSION; MENTAL DEFICIENCY; RANDOM AMPLIFIED POLYMORPHIC DNA; RESPIRATORY DISTRESS; SEPSIS; SPEECH DISORDER; STAPHYLOCOCCUS LUGDUNENSIS; TOOTH ERUPTION; TOOTH PLAQUE;

22Q11 DELETION SYNDROME; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS LUGDUNENSIS;

EID: 84857186569     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6257     Document Type: Article

References (25)

1. Swillen A, Vogels A, Devriendt K, Fryns JP. Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet 97: 128-135, 2000.
2. Kinoshita O, Mizoue T, Kusama A, et al. Pulmonary arterial aneurysm with CATCH 22 syndrome-a case report. Angiology 52: 789-791, 2001.
3. Boudjemline Y, Le Bidois J, Agnoletti G, Iserin F, Sidi D, Bonnet D. Images in cardiovascular medicine. Unusual form of truncus arteriosus associated with 22q11 deletion. Circulation 106: e191, 2002.
4. Marmon LM, Balsara RK, Chen R, Dunn JM. Congenital cardiac anomalies associated with the DiGeorge syndrome: a neonatal experience. Ann Thorac Surg 38: 146-150, 1984.
5. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30: 633-638, 2000.
6. Casey AL, Worthington T, Caddick JM, Hilton AC, Lambert PA, Elliott TS. RAPD for the typing of coagulase-negative staphylococci implicated in catheter-related bloodstream infection. J Infect 52: 282-289, 2006.
7. Yonehara Y, Nakatsuka T, Ichioka S, Sasaki N, Kobayashi T. CATCH 22 syndrome. J Craniofac Surg 13: 623-626, 2002.
8. Fujii I, Ueno Y, Kurano R, Goto Y. Interrupted aortic arch type C associated with DiGeorge syndrome in 22q11.2 deletion: first case detected in Japan. Pediatr Int 47: 698-700, 2005.
9. Driscoll DA, Salvin J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 30: 813-817, 1993.
10. van Engelen K, Topf A, Keavney BD, et al. 22q11.2 Deletion syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. Heart 96: 621-624, 2010.
11. Waters V, Peterson KS, LaRussa P. Live viral vaccines in a Di- George syndrome patient. Arch Dis Child 92: 519-520, 2007.
12. Sane SY. DiGeorge syndrome with multiple infections an autopsy report. J Postgrad 35: 114-115, 1989.
13. Eberle P, Berger C, Junge S, et al. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome. Clin Exp Immunol 155: 189-198, 2008.
14. + Tlymphocytopenia. J Clin Invest 97: 672-680, 1996.
15. Hirasaki S, Koide N, Ogawa H, Tsuji T. Active intestinal tuberculosis with esophageal candidiasis due to idiopathic CD4(+) Tlymphocytopenia in an elderly woman. J Gastroenterol 35: 47-51,2000.
16. Chang AD, Tachdjian R, Gallagher K, et al. Type III mixed cryoglobulinemia and antiphospholipid syndrome in a patient with partial DiGeorge syndrome. Clin Dev Immunol 13: 261-264, 2006.
17. Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86: 422-425, 2002.
18. Fukui N, Amano A, Akiyama S, Daikoku H, Wakisaka S, Morisaki I. Oral findings in DiGeorge syndrome: clinical features and histologic study of primary teeth. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 208-215, 2000.
19. Borglum Jensen S, Jacobsen P, Rotne L, Enk C, Illum F. Oral findings in DiGeorge syndrome. Int J Oral Surg 12: 250-254, 1983.
20. Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol 29: 419-421, 1991.
21. Frank KL, Del Pozo JL, Patel R. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 21: 111-133, 2008.
22. Choi SH, Chung JW, Lee EJ, et al. Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia. J Clin Microbiol 48: 3346-3349, 2010.
23. Maeto M, Maestre JR, Aguilar L, et al. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis. J Antimicrob Chemother 56: 287-291, 2005.
24. Pereira EM, Schuenck RP, Nouér SA, Santos KR. Methicillinresistant Staphylococcus lugdunensis carrying SCCmec type V misidentified as MRSA. Braz J Infect Dis 15: 293-295, 2011.
25. Seenivasan MH, Yu VL. Staphylococcus lugdunensis endocarditis- the hidden peril of coagulase-negative staphylococcus in blood cultures. Eur J Clin Microbiol Infect Dis 22: 489-491, 2003.